Evidence map›Paper›PMID 22180498›Full record

ArticleEndocrine-related cancer2012

Should diabetic women with breast cancer have their own intervention studies?

David A Potter, Douglas Yee, Zhijun Guo, Mariangellys Rodriguez

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Endocrine-related cancer, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 87% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

David A PotterDivision of Hematology, Oncology and Transplantation, Masonic Cancer Center, University of Minnesota, 420 Delaware Street SouthEast, MMC 480, Minneapolis, Minnesota 55455-0392, USA. dapotter@umn.edu
Douglas Yee
Zhijun Guo
Mariangellys Rodriguez
University of Minnesota · USPalmetto Hematology Oncology · USUniversity of Minnesota Medical Center · US

Funding

Women's CancerP30CA077598 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Douglas Yee · 1998 to 2026
$100.4M
TARGETING THE IGF SYSTEM IN BREAST CANCERR01CA074285 · NCI · UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT · PI YEE, DOUGLAS · 1998 to 2012
$4.0M
Epoxygenease Mechanisms of Breast Cancer ProgressionR01CA113570 · NCI · UNIVERSITY OF MINNESOTA · PI POTTER, DAVID ALEXANDER · 2005 to 2008
$918k
Role of IGF-1R in breast cancer proliferation and survival via CYP1A1 epoxygenaseF31CA144084 · NCI · UNIVERSITY OF MINNESOTA · PI RODRIGUEZ, MARIANGELLYS · 2009 to 2012
$106k
NCI NIH HHS 5F31CA144084NCI NIH HHS F31 CA144084NCI NIH HHS P30 CA077598NCI NIH HHS P30CA077598NCI NIH HHS R01 CA074285NCI NIH HHS R01CA074285NCI NIH HHS R01 CA113570NCI NIH HHS R01CA113570
6 · The paper itself

Abstract

This commentary on 'Calorie restriction and rapamycin inhibit MMTV-Wnt-1 mammary tumor growth in a mouse model of postmenopausal obesity' by Nogueira et al., published in this issue of Endocrine-Related Cancer, addresses the challenges of translating diet, exercise, and pharmacologic trials in diabetic mouse mammary tumor models to human studies. We propose that trials specifically designed to test such interventions in diabetic women with breast cancer would be valuable and informative.

Indexed as

Caloric RestrictionDiet TherapyExerciseAnimalsAntineoplastic AgentsBreast NeoplasmsClinical Trials as TopicDiabetes Mellitus, Type 2FemaleHumansMiceObesityAntineoplastic Agents

Identifiers

PMID22180498
PMCPMC3680369
OpenAlexW2144890139

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.